Insulin: The First FDA-Approved Peptide Drug That Changed Medicine
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Discover the story of insulin, the first FDA-approved peptide drug that transformed diabetes from a fatal disease to a manageable condition. Learn about its history.
Insulin: A Revolutionary Peptide That Transformed Medicine
For centuries, a diagnosis of diabetes was a death sentence. This devastating disease, characterized by the body's inability to regulate blood sugar, led to a host of debilitating complications and, ultimately, a premature death. But the discovery of insulin in the early 1920s, and its subsequent approval as the insulin first peptide drug FDA, marked a turning point in the history of medicine. This revolutionary peptide therapeutic transformed diabetes from a fatal illness into a manageable chronic condition, saving millions of lives and paving the way for the development of a new class of drugs. This article explores the history of insulin, from its discovery to its FDA approval and its profound impact on medicine and the lives of patients with diabetes.
The Grim Reality of Diabetes Before Insulin
Before the discovery of insulin, diabetes was a feared and misunderstood disease. Physicians knew that the urine of diabetics was sweet, and they observed the symptoms of excessive thirst, urination, and weight loss. However, they had no effective treatments. The most common prescription was a starvation diet, which involved severely restricting calories to the point of malnourishment. While this could extend a patient's life by a few months, it was a miserable existence that ultimately ended in death from either the disease or starvation. The lack of understanding of the underlying cause of diabetes meant that patients had little hope for a normal life.
A Breakthrough Discovery: The Isolation of Insulin
The story of insulin's discovery is a testament to scientific perseverance. In 1921, a team of Canadian researchers—Frederick Banting, Charles Best, J.J.R. Macleod, and James Collip—embarked on a quest to isolate the elusive pancreatic secretion responsible for regulating blood sugar. PMID: 23864881 Their work, conducted at the University of Toronto, involved ligating the pancreatic ducts of dogs to destroy the digestive enzyme-producing parts of the pancreas, leaving the islets of Langerhans intact. They then created an extract from these islets, which they called "isletin."
In January 1922, they administered this extract to a 14-year-old boy named Leonard Thompson, who was dying from diabetes. The results were miraculous. The boy's blood sugar levels dropped, and his condition improved dramatically. This marked the first successful treatment of diabetes with insulin. The discovery was hailed as a medical miracle and earned Banting and Macleod the Nobel Prize in Physiology or Medicine in 1923, which they shared with Best and Collip. The team patented their discovery but sold the patent to the University of Toronto for a mere $1, ensuring that this life-saving treatment would be accessible to all.
The Dawn of a New Era: FDA Approval and Biosynthetic Insulin
The initial insulin preparations were derived from the pancreases of cows and pigs. While effective, these animal-derived insulins could cause allergic reactions in some patients. The development of recombinant DNA technology in the 1970s opened the door to producing a purer, more consistent form of insulin. In 1978, scientists at Genentech successfully produced the first biosynthetic human insulin, known as Humulin, using E. coli bacteria. PMID: 6124760
This was a groundbreaking achievement, as it marked the first time a human protein had been produced through genetic engineering. After rigorous testing, Eli Lilly and Company submitted a New Drug Application to the FDA. On October 28, 1982, the FDA approved Humulin, making it the first recombinant DNA drug and the insulin first peptide drug FDA to be approved for human use. FDA.gov This landmark decision not only provided a safer and more reliable source of insulin for diabetics but also ushered in the age of biotechnology, paving the way for the development of numerous other life-saving biologic drugs.
Types of Insulin
Today, there are many different types of insulin available, each with a different onset, peak, and duration of action. This allows for more precise control of blood sugar levels. The following table summarizes the different types of insulin:
| Insulin Type | Onset of Action | Peak Action | Duration of Action |
| :--- | :--- | :--- | :--- |
| Rapid-acting | 15 minutes | 1-2 hours | 2-4 hours |
| Short-acting (Regular) | 30 minutes | 2-3 hours | 3-6 hours |
| Intermediate-acting | 2-4 hours | 4-12 hours | 12-18 hours |
| Long-acting | Several hours | No peak | 24 hours or longer |
| Ultra long-acting | 6 hours | No peak | 36 hours or longer |
| Inhaled insulin | 12-15 minutes | 30 minutes | 2-3 hours |
This variety of insulin formulations allows healthcare providers to create individualized treatment plans that mimic the body's natural insulin secretion and effectively manage blood sugar levels throughout the day. Patients can learn more about their options by visiting our extensive `/library`.
---
The specialists at TeleGenix can help you understand the different types of insulin and develop a personalized treatment plan that is right for you. They offer a comprehensive approach to diabetes management, including the latest in peptide therapies. Visit their website to learn more about how they can help you live a healthier life with diabetes.
---
The Profound Impact of Insulin on Life and Health
The availability of insulin has had a profound impact on the lives of people with diabetes. Before insulin, the life expectancy for a person with type 1 diabetes was just a few years. Today, with proper management, people with diabetes can live long, healthy, and productive lives. Insulin has not only increased life expectancy but has also dramatically improved the quality of life for millions of people. It has allowed them to avoid the devastating complications of uncontrolled diabetes, such as blindness, kidney failure, and amputations. The development of the insulin first peptide drug FDA truly revolutionized the management of this chronic disease.
For those interested in exploring other groundbreaking treatments, our `/peptide-therapy-guide` offers a wealth of information on the latest advancements in peptide-based medicine.
The Future of Insulin Therapy
Research into insulin and diabetes management continues to advance at a rapid pace. Scientists are exploring new ways to deliver insulin, such as oral pills and smart insulin patches that automatically release insulin in response to blood sugar levels. PMID: 38566433 Gene therapy is also being investigated as a potential cure for type 1 diabetes. As our understanding of the complex interplay of hormones and metabolism grows, we can expect to see even more innovative treatments for diabetes in the future. You can explore and `/compare` different treatment options on our website.
For those dealing with related health concerns, such as low testosterone, our `/testosterone-library` provides valuable resources. If you are looking for care, you can find a qualified provider in your area with our `/trt-near-me` tool. Our `/compounds` and `/conditions` pages also offer more in-depth information on a variety of health topics.
References
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.
---